1. Home
  2. GLSI vs BFIN Comparison

GLSI vs BFIN Comparison

Compare GLSI & BFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLSI
  • BFIN
  • Stock Information
  • Founded
  • GLSI 2006
  • BFIN 1924
  • Country
  • GLSI United States
  • BFIN United States
  • Employees
  • GLSI N/A
  • BFIN N/A
  • Industry
  • GLSI Biotechnology: Pharmaceutical Preparations
  • BFIN Savings Institutions
  • Sector
  • GLSI Health Care
  • BFIN Finance
  • Exchange
  • GLSI Nasdaq
  • BFIN Nasdaq
  • Market Cap
  • GLSI 134.6M
  • BFIN 145.5M
  • IPO Year
  • GLSI 2020
  • BFIN N/A
  • Fundamental
  • Price
  • GLSI $11.65
  • BFIN $12.46
  • Analyst Decision
  • GLSI Strong Buy
  • BFIN Hold
  • Analyst Count
  • GLSI 1
  • BFIN 1
  • Target Price
  • GLSI $39.00
  • BFIN $11.50
  • AVG Volume (30 Days)
  • GLSI 45.8K
  • BFIN 120.8K
  • Earning Date
  • GLSI 08-14-2025
  • BFIN 08-06-2025
  • Dividend Yield
  • GLSI N/A
  • BFIN 3.23%
  • EPS Growth
  • GLSI N/A
  • BFIN N/A
  • EPS
  • GLSI N/A
  • BFIN 0.16
  • Revenue
  • GLSI N/A
  • BFIN $45,545,000.00
  • Revenue This Year
  • GLSI N/A
  • BFIN N/A
  • Revenue Next Year
  • GLSI N/A
  • BFIN $6.40
  • P/E Ratio
  • GLSI N/A
  • BFIN $79.01
  • Revenue Growth
  • GLSI N/A
  • BFIN N/A
  • 52 Week Low
  • GLSI $8.06
  • BFIN $10.69
  • 52 Week High
  • GLSI $16.50
  • BFIN $13.97
  • Technical
  • Relative Strength Index (RSI)
  • GLSI 53.04
  • BFIN 67.07
  • Support Level
  • GLSI $11.51
  • BFIN $12.29
  • Resistance Level
  • GLSI $12.07
  • BFIN $12.50
  • Average True Range (ATR)
  • GLSI 0.58
  • BFIN 0.23
  • MACD
  • GLSI -0.07
  • BFIN 0.14
  • Stochastic Oscillator
  • GLSI 31.86
  • BFIN 94.48

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

About BFIN BankFinancial Corporation

BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.

Share on Social Networks: